Previous studies have shown that AURKB overexpression is associated with tumor progression in renal cell carcinoma [14], lung cancer [15], anaplastic thyroid carcinoma [16], hepatocellular carcinoma [17], and head and neck squamous cell carcinoma [18]. Here, AURKB is linked to renal cell carcinoma.